Document Detail

Peripartum cardiomyopathy.
MedLine Citation:
PMID:  16920474     Owner:  NLM     Status:  MEDLINE    
Peripartum cardiomyopathy (PPCM) is a disorder in which initial left ventricular systolic dysfunction and symptoms of heart failure occur between the late stages of pregnancy and the early postpartum period. It is common in some countries and rare in others. The causes and pathogenesis are poorly understood. Molecular markers of an inflammatory process are found in most patients. Clinical presentation includes usual signs and symptoms of heart failure, and unusual presentations relating to thromboembolism. Clinicians should consider PPCM in any peripartum patient with unexplained disease. Conventional heart failure treatment includes use of diuretics, beta blockers, and angiotensin-converting enzyme inhibitors. Effective treatment reduces mortality rates and increases the number of women who fully recover left ventricular systolic function. Outcomes for subsequent pregnancy after PPCM are better in women who have first fully recovered heart function. Areas for future research include immune system dysfunction, the role of viruses, non-conventional treatments such as immunosuppression, immunoadsorption, apheresis, antiviral treatment, suppression of proinflammatory cytokines, and strategies for control and prevention.
Karen Sliwa; James Fett; Uri Elkayam
Related Documents :
25456414 - Prospective, multi-center evaluation of a silicon carbide coated cobalt chromium bare m...
12798834 - The diagnosis of heart failure in general practice: implications for the uk national se...
15325474 - Use of pimobendan in the management of heart failure.
8682054 - Aldosterone escape during ace inhibitor therapy in chronic heart failure.
92414 - N-acetylprocainamide and ischemia-induced ventricular fibrillation in the dog.
17532944 - Initial results of the chordal-cutting operation for ischemic mitral regurgitation.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Lancet     Volume:  368     ISSN:  1474-547X     ISO Abbreviation:  Lancet     Publication Date:  2006 Aug 
Date Detail:
Created Date:  2006-08-21     Completed Date:  2006-09-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  England    
Other Details:
Languages:  eng     Pagination:  687-93     Citation Subset:  AIM; IM    
Soweto Cardiovascular Research Unit, Department of Cardiology, Chris-Hani-Baragwanath Hospital, University of the Witwatersrand, P O Bertsham 2013, Johannesburg, South Africa.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Cardiomyopathies* / drug therapy,  mortality,  physiopathology
Diuretics / therapeutic use*
Middle Aged
Postpartum Period
Pregnancy Complications, Cardiovascular* / drug therapy,  mortality,  physiopathology
Risk Factors
Ventricular Function, Left
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Diuretics

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effective...
Next Document:  Central nervous system injury associated with cardiac surgery.